In Vitro Diagnostics | Market Insights | US | 2025
The US IVD market is expected to grow moderately through 2033, driven by the increasing prevalence of chronic and infectious diseases, the expanding aging population, and the shift toward value-based healthcare, which will fuel the uptake of novel tests and automated IVD systems that can offer improved diagnostic accuracy and reduced turnaround time.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for IVDs in the US from 2019 through 2033.